BIEL — BioElectronics Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $4.94m
- $18.28m
- $1.61m
Annual income statement for BioElectronics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | USG | — | — | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.76 | 1.05 | 0.942 | 0.83 | 1.61 |
| Cost of Revenue | |||||
| Gross Profit | 0.998 | 0.357 | 0.53 | 0.506 | 0.796 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Total Operating Expenses | 3.12 | 3.08 | 2.27 | 1.88 | 1.76 |
| Operating Profit | -1.36 | -2.04 | -1.33 | -1.05 | -0.154 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -2.12 | -2.99 | -2.33 | -1.16 | -0.29 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.12 | -2.99 | -2.33 | -1.16 | -0.29 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -2.12 | -2.99 | -2.33 | -1.16 | -0.29 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.12 | -2.99 | -2.33 | -1.16 | -0.29 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0 | -0 | -0 | -0 | -0 |